Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
The nuclear factor-kappaB (NF-κB) signaling pathway is considered as a potential
therapeutic target in cancer therapy. It has been well established that transcription factor NF …
therapeutic target in cancer therapy. It has been well established that transcription factor NF …
[HTML][HTML] Artificial intelligence in pancreatic cancer
B Huang, H Huang, S Zhang, D Zhang, Q Shi, J Liu… - Theranostics, 2022 - ncbi.nlm.nih.gov
Pancreatic cancer is the deadliest disease, with a five-year overall survival rate of just 11%.
The pancreatic cancer patients diagnosed with early screening have a median overall …
The pancreatic cancer patients diagnosed with early screening have a median overall …
The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer
DC McMillan - Cancer treatment reviews, 2013 - Elsevier
Since the initial work, a decade ago that the combination of C-reactive protein and albumin,
the Glasgow Prognostic Score (GPS), had independent prognostic value in patients with …
the Glasgow Prognostic Score (GPS), had independent prognostic value in patients with …
The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: systematic review and meta-analysis
Cancer remains a leading causes of death worldwide and an elevated systemic
inflammatory response (SIR) is associated with reduced survival in patients with operable …
inflammatory response (SIR) is associated with reduced survival in patients with operable …
Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy
BW Miller, JP Morton, M Pinese, G Saturno… - EMBO molecular …, 2015 - embopress.org
Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer‐related
mortality. Despite significant advances made in the treatment of other cancers, current …
mortality. Despite significant advances made in the treatment of other cancers, current …
Clinical impact of nutrition and inflammation assessment tools in pancreatic cancer treatment
T Aoyama, Y Maezawa, I Hashimoto, Y Rino… - Anticancer …, 2023 - ar.iiarjournals.org
Perioperative adjuvant treatment and complete resection is the standard treatment for
resectable pancreatic cancer and systemic chemotherapy is standard treatment for …
resectable pancreatic cancer and systemic chemotherapy is standard treatment for …
The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma–a systematic review and meta-analysis
Objectives To assess the impact of neural invasion/NI on overall survival/OS and tumor
recurrence in pancreatic ductal adenocarcinoma/PDAC. Summary background data NI is a …
recurrence in pancreatic ductal adenocarcinoma/PDAC. Summary background data NI is a …
Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma
F Noble, T Mellows, LH McCormick Matthews… - Cancer Immunology …, 2016 - Springer
Background Oesophageal adenocarcinoma (OAC) is increasingly common in the west, and
survival remains poor at 10–15% at 5 years. Immune responses are increasingly implicated …
survival remains poor at 10–15% at 5 years. Immune responses are increasingly implicated …
[HTML][HTML] Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma
P Lohneis, M Sinn, S Bischoff, A Jühling… - European journal of …, 2017 - Elsevier
Background We studied the prognostic effect of CD3-, CD8-and CD103-positive T
lymphocytes in a cohort of 165 patients with resected pancreatic ductal adenocarcinomas …
lymphocytes in a cohort of 165 patients with resected pancreatic ductal adenocarcinomas …
[HTML][HTML] MMP1/PAR1/SP/NK1R paracrine loop modulates early perineural invasion of pancreatic cancer cells
C Huang, Y Li, Y Guo, Z Zhang, G Lian, Y Chen, J Li… - Theranostics, 2018 - ncbi.nlm.nih.gov
The molecular mechanism of perineural invasion (PNI) is unclear, and insufficient detection
during early-stage PNI in vivo hampers its investigation. We aimed to identify a cytokine …
during early-stage PNI in vivo hampers its investigation. We aimed to identify a cytokine …